Mirova US LLC Acquires 1,659 Shares of Colgate-Palmolive (NYSE:CL)

Mirova US LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 16.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 11,849 shares of the company’s stock after purchasing an additional 1,659 shares during the period. Mirova US LLC’s holdings in Colgate-Palmolive were worth $1,077,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CL. Swedbank AB raised its holdings in shares of Colgate-Palmolive by 1.4% in the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after purchasing an additional 40,324 shares during the period. OneDigital Investment Advisors LLC raised its holdings in shares of Colgate-Palmolive by 23.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 14,829 shares of the company’s stock valued at $1,539,000 after purchasing an additional 2,847 shares during the period. Natixis Advisors LLC raised its holdings in shares of Colgate-Palmolive by 15.5% in the 3rd quarter. Natixis Advisors LLC now owns 386,681 shares of the company’s stock valued at $40,141,000 after purchasing an additional 51,991 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Colgate-Palmolive by 39.8% in the 3rd quarter. Thrivent Financial for Lutherans now owns 90,023 shares of the company’s stock valued at $9,345,000 after purchasing an additional 25,645 shares during the period. Finally, Quest Partners LLC raised its holdings in Colgate-Palmolive by 69.6% in the 3rd quarter. Quest Partners LLC now owns 31,829 shares of the company’s stock valued at $3,304,000 after acquiring an additional 13,066 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $90.72 on Tuesday. Colgate-Palmolive has a 52-week low of $85.32 and a 52-week high of $109.30. The stock has a market capitalization of $73.62 billion, a price-to-earnings ratio of 25.77, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a fifty day moving average of $89.09 and a 200-day moving average of $94.56. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company posted $0.87 earnings per share. Equities research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Friday. Barclays lowered their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Raymond James reissued an “outperform” rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday. Finally, Piper Sandler lowered their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $101.72.

View Our Latest Stock Report on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.